Near-infrared light and glucose dual-responsive cascading hydroxyl radical generation for in situ gelation and effective breast cancer treatment
Source abstract
Abstract
A general therapeutic strategy to treat breast cancer is attractive as different subtypes of breast cancers often exhibit distinct response to existing cancer therapeutics. To this end, we prepare a catalyst couple of glucose oxidase (GOx) and gallic acid-ferrous (GA-Fe) nanocomplexes, a type of near-infrared (NIR) absorbing Fenton catalyst, to enable NIR-trigger in-situ gelation and enhanced chemodynamic/starvation therapy that appears to be effective for different types of breast cancer cells. In this system, GOx is mixed with GA-Fe in a solution of N,N-dimethylacrylamide (DMAA) and poly (ethylene glycol) double acrylate (PEGDA). Upon intratumoral injection and NIR laser exposure, such GA-Fe show rapid temperature increase, which would simultaneously increase the catalytic efficiencies of GA-Fe and GOx. The cascade production of hydroxyl radicals (•OH) from glucose is then initiated to enable polymerization of DMAA and PEGDA to form a hydrogel at the injection site within the tumor. The continuous production of cytotoxic •OH together with glucose depletion by the intratumorally fixed catalyst couple would further confer effective destruction of breast cancer tumors by such chemodynamic/starvation therapy. Our work presents a hydrogel-based therapeutic strategy for local treatment of solid tumors with high tumor destruction efficacy and low systemic toxicity.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Global cancer statistics
2. Breast cancer: epidemiology and etiology10.1007/s12013-014-0459-6 ↗
3. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes10.1158/1078-0432.CCR-06-1109 ↗
4. Triple-negative breast cancer: clinical features and patterns of recurrence10.1158/1078-0432.CCR-06-3045 ↗
5. Metastatic breast cancer: the treatment challenge
6. Breast cancer molecular subtypes respond differently to preoperative chemotherapy10.1158/1078-0432.CCR-04-2421 ↗
7. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness10.1177/1534735404270335 ↗
8. Polymorphisms in genes related to oxidative stress (CAT, MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer10.1158/1078-0432.CCR-06-0039 ↗
9. Meijer · 2012
10. Modulation of oxidative stress as an anticancer strategy10.1038/nrd4002 ↗
11. Oxidative stress in cancer and fibrosis: opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles10.1016/j.redox.2016.12.011 ↗
12. ROS‐responsive drug delivery systems10.1002/btm2.10014 ↗
13. Chemodynamic therapy: tumour microenvironment‐mediated Fenton and fenton‐like reactions10.1002/anie.201805664 ↗
14. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy10.7150/thno.5411 ↗
15. Synthesis of iron nanometallic glasses and their application in cancer therapy by a localized Fenton reaction10.1002/anie.201510031 ↗
16. Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors10.1021/acsnano.8b06201 ↗
17. Nanocatalytic tumor therapy by single-atom catalysts
18. Near infrared-assisted Fenton reaction for tumor-specific and mitochondrial DNA-targeted photochemotherapy10.1016/j.biomaterials.2017.06.035 ↗
19. Polymer prodrug-based nanoreactors activated by tumor acidity for orchestrated oxidation/chemotherapy10.1021/acs.nanolett.7b03531 ↗
20. Amplification of tumor oxidative stresses with liposomal Fenton catalyst and glutathione inhibitor for enhanced cancer chemotherapy and radiotherapy10.1021/acs.nanolett.8b03905 ↗
21. Self-assembled copper–amino acid nanoparticles for in situ glutathione “AND” H2O2 sequentially triggered chemodynamic therapy10.1021/jacs.8b08714 ↗
22. One‐dimensional Fe2P acts as a Fenton agent in response to NIR II light and ultrasound for deep tumor synergetic theranostics10.1002/anie.201813702 ↗
23. Antiferromagnetic pyrite as the tumor microenvironment‐mediated nanoplatform for self‐enhanced tumor imaging and therapy10.1002/adma.201701683 ↗
24. Remote control of intracellular calcium using upconversion nanotransducers regulates stem cell differentiation in vivo10.1002/adfm.201802642 ↗
25. Near-infrared light-controlled regulation of intracellular calcium to modulate macrophage polarization10.1016/j.biomaterials.2018.03.007 ↗
26. Enhanced phototherapy by nanoparticle-enzyme via generation and photolysis of hydrogen peroxide10.1021/acs.nanolett.7b01382 ↗
27. Magnetic targeting, tumor microenvironment-responsive intelligent nanocatalysts for enhanced tumor ablation10.1021/acsnano.8b05042 ↗
28. Therapeutic polymersome nanoreactors with tumor-specific activable cascade reactions for cooperative cancer therapy
29. Fabrication of H2O2-driven nanoreactors for innovative cancer treatments10.1039/C9NR04418C ↗
30. Glucose oxidase‐instructed multimodal synergistic cancer therapy10.1002/adma.201808325 ↗
31. Nano-Fenton reactors as a new class of oxidative stress amplifying anticancer therapeutic agents10.1021/acsami.5b12523 ↗
32. A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis10.1038/s41467-018-07197-8 ↗
33. An adenosine triphosphate-responsive autocatalytic Fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe (III)/Fe (II) conversion10.1021/acs.nanolett.8b03178 ↗
34. Erythrocyte membrane cloaked metal–organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy10.1021/acsnano.8b05200 ↗
35. Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy10.1016/j.biomaterials.2018.02.004 ↗
36. Engineering of a nanosized biocatalyst for combined tumor starvation and low-temperature photothermal therapy10.1021/acsnano.8b00309 ↗
37. The antioxidant, rather than prooxidant, activities of quercetin on normal cells:: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis10.1016/S0014-4827(03)00410-5 ↗
38. Critical role of poly (ADP‐ribose) polymerase‐1 in modulating the mode of cell death caused by continuous oxidative stress10.1002/jcb.22332 ↗
39. A reversibly antigen-responsive hydrogel10.1038/21619 ↗
40. Polypyrrole-hydrogel composites for the construction of clinically important biosensors10.1016/S0956-5663(01)00262-7 ↗
41. Dephosphorylation of D-peptide derivatives to form biofunctional, supramolecular nanofibers/hydrogels and their potential applications for intracellular imaging and intratumoral chemotherapy10.1021/ja404215g ↗
42. Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy10.1073/pnas.1405469111 ↗
43. Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses10.1038/s41551-018-0262-6 ↗
44. Oxidoreductase‐initiated radical polymerizations to design hydrogels and micro/nanogels: mechanism, molding, and applications10.1002/adma.201705668 ↗
45. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment10.1038/s41565-018-0319-4 ↗
46. Near-infrared-triggered in situ gelation system for repeatedly enhanced photothermal brachytherapy with a single dose10.1021/acsnano.8b04544 ↗
47. Rational design of a tetrameric protein to enhance interactions between self‐assembled fibers gives molecular hydrogels10.1002/anie.201108612 ↗
48. Enzyme‐catalyzed formation of supramolecular hydrogels as promising vaccine adjuvants10.1002/adfm.201505188 ↗
49. Implantable tin porphyrin-PEG hydrogels with pH-responsive fluorescence10.1021/acs.biomac.6b01715 ↗
50. Surfactant-stripped micelles of near infrared dye and paclitaxel for photoacoustic imaging guided photothermal-chemotherapy10.1002/smll.201802991 ↗
51. Simultaneous fenton‐like ion delivery and glutathione depletion by MnO2‐based nanoagent to enhance chemodynamic therapy10.1002/anie.201712027 ↗
52. Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications10.1038/ncomms9003 ↗
53. ROS stress in cancer cells and therapeutic implications10.1016/j.drup.2004.01.004 ↗
54. Glucose oxidase–polymer nanogels for synergistic cancer-starving and oxidation therapy10.1021/acsami.7b06814 ↗